Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response
- Peter Ferenci
- , Hermann Laferl
- , Thomas-Matthias Scherzer
- , Michael Gschwantler
- , Andreas Maieron
- , Harald Brunner
- , Rudolf Stauber
- , Martin Bischof
- , Bernhard Bauer
- , Christian Datz (Co-Autor/-in)
- , Karin Löschenberger
- , Elisabeth Formann
- , Katharina Staufer
- , Petra Steindl-Munda
- , Austrian Hepatitis Study Group
- Medical School and University Medical Center OWL
Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung